PB
AGN

Pinnacle Bancorp’s Allergan plc AGN Stock Holding History

Pinnacle Bancorp’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-40
Closed -$7K – 681
2020
Q1 		$7K Sell
40
-157
-80% -$29.6K 0.01% 554
2019
Q4 		$38K Hold
197
– – 0.03% 351
2019
Q3 		$33K Hold
197
– – 0.02% 368
2019
Q2 		$33K Hold
197
– – 0.02% 370
2019
Q1 		$29K Buy
197
+30
+18% +$4.35K 0.02% 384
2018
Q4 		$22K Buy
+167
New +$27.4K 0.01% 413

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Pinnacle Bancorp's AGN Position: Q2 2020 in Review

Pinnacle Bancorp sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 40 shares — an estimated $7K sold.

Pinnacle Bancorp first reported a position in AGN in Q4 2018 and held it in 6 quarters. The position peaked at $38K in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Pinnacle Bancorp reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Pinnacle Bancorp sold 40 Allergan plc shares in Q2 2020, an estimated $7K.
  • Pinnacle Bancorp first reported a position in Allergan plc in Q4 2018 and held it in 6 quarters.
  • Pinnacle Bancorp's Allergan plc position peaked at $38K in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Pinnacle Bancorp's 13F filing for Q2 2020, filed 7 Jul 2020.